Global Cancer Therapeutics And Biotherapeutics Market is Estimated to Witness High Growth
The global cancer therapeutics and biotherapeutics market involves the development and commercialization of drugs and biologics for treating various types of cancers. Advancements in fields like gene therapy, immunotherapy, targeted therapy have revolutionized the treatment landscape for cancer patients. Gene therapy involves modifying the genetic material of cells to fight cancer and is emerging as a promising approach for effectively treating various cancers.
The Global cancer therapeutics and biotherapeutics market is estimated to be valued at US$ 194.11 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031.
Key players operating in the global cancer therapeutics and biotherapeutics market are Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, ELI Lilly and Company, Hoffmann-La Roche AG, EnGeneIC Ltd, Merck & Co Inc., Novartis, Pfizer Inc., Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, Biogen IDEC, Sanofi, Novartis AG, Roche, Schering-Plough, Gilead Sciences, and Takeda Pharmaceutical Company.
Key Takeaways
Key players - Key players operating in the Global Cancer Therapeutics And Biotherapeutics Market Share are focused towards gaining approval for novel therapies and expanding their product portfolios through acquisitions and partnerships.
Key opportunities - Increasing research funding for cancer and advancements in fields such as personalized medicine and immuno-oncology are expected to create lucrative opportunities.
Get More Insights On, Global Cancer Therapeutics And Biotherapeutics Market
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian